Dr. Eng is a national and international leader in gastrointestinal medical oncology and the David H. Johnson Chair in Surgical and Medical Oncology at the Vanderbilt-Ingram Cancer Center. She joined the faculty at Vanderbilt-Ingram Cancer Center in July 2019 after over 17 years at the MD Anderson Cancer Center. Her primary clinical research interests include clinical trials involving innovative drugs for the treatment of colorectal, anal, and appendiceal cancers. She has a specific interest in young colorectal cancer patients as well as the role of immunotherapy in HPV-associated cancers. She has published multiple publications in these GI malignancies.
Nationally, Dr. Eng has served in multiple leadership roles for ASCO, ASCO GI, ECOG, and the NCI Rectal/Anal Task Force. She has most recently been chosen to serve as the Vice-Chair for the SWOG GI Committee and the NCI GI Steering Committee.
Dr. Eng received her medical degree from Hahnemann University School of Medicine in Philadelphia. She completed residency in internal medicine at Rush University Medical Center and a fellowship in hematology and oncology at University of Chicago Medical Center.